Literature DB >> 21110169

Pancreatic neuroendocrine cell tumor secreting parathyroid hormone-related protein and gastrin: Report of a case.

Yoshifumi Morita1, Shohachi Suzuki, Takanori Sakaguchi, Kosuke Oishi, Atsushi Suzuki, Kazuhiko Fukumoto, Keisuke Inaba, Satoshi Baba, Yasuo Takehara, Hiroyuki Konno.   

Abstract

This report presents a case of pancreatic neuroendocrine cell carcinoma with multiple liver metastases secreting gastrin and parathyroid hormone-related protein (PTHrP) related to lumbar bone fracture and hypercalcemia. A 58-year-old woman visited an affiliated hospital with a chief complaint of lumbago without any evidence of trauma. She was diagnosed with hepatic dysfunction and hypercalcemia as well as multiple lumbar compression fractures without osteolytic lesions. Abdominal computed tomography (CT) showed a hypervascular mass in the pancreatic tail and multiple liver tumors. Duodenal ulcers were found with gastrointestinal endoscopy. There was a marked increase in the serum gastrin level. She was diagnosed as gastrinoma with multiple liver metastases and was admitted to the hospital. She had an increase in serum PTHrP level without the elevation of intact parathyroid hormone at the time of admission. She underwent an extended right hepatectomy in addition to a distal pancreatectomy with a regional lymphadenectomy and splenectomy. The postoperative course was uneventful, and serum gastrin and PTHrP activities reduced to normal levels. She remained symptom-free, and serum calcium, gastrin, and PTHrP levels remain within the normal ranges 19 months after surgery without adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110169     DOI: 10.1007/s00595-009-4190-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.

Authors:  Francesco Panzuto; Silvia Nasoni; Massimo Falconi; Vito Domenico Corleto; Gabriele Capurso; Sara Cassetta; Michela Di Fonzo; Valentina Tornatore; Massimo Milione; Stefano Angeletti; Maria Sofia Cattaruzza; Vincenzo Ziparo; Cesare Bordi; Paolo Pederzoli; Gianfranco Delle Fave
Journal:  Endocr Relat Cancer       Date:  2005-12       Impact factor: 5.678

2.  Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.

Authors:  Homayoun Shojamanesh; Fathia Gibril; Adeline Louie; Jeremiah V Ojeaburu; Showkat Bashir; Alaa Abou-Saif; Robert T Jensen
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

3.  Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis.

Authors:  Srinevas K Reddy; Timothy M Pawlik; Daria Zorzi; Ana L Gleisner; Dario Ribero; Lia Assumpcao; Andrew S Barbas; Eddie K Abdalla; Michael A Choti; Jean-Nicolas Vauthey; Kirk A Ludwig; Christopher R Mantyh; Michael A Morse; Bryan M Clary
Journal:  Ann Surg Oncol       Date:  2007-09-01       Impact factor: 5.344

4.  The gastrinoma triangle: operative implications.

Authors:  B E Stabile; D J Morrow; E Passaro
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

5.  Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.

Authors:  J A Norton; J L Doppman; R T Jensen
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

6.  Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach.

Authors:  Juan M Sarmiento; Florencia G Que; Clive S Grant; Geoffrey B Thompson; Michael B Farnell; David M Nagorney
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

Review 7.  Pancreatic neuroendocrine tumours.

Authors:  H L O'Grady; K C Conlon
Journal:  Eur J Surg Oncol       Date:  2007-10-29       Impact factor: 4.424

8.  Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

Authors:  C G Moertel; M Lefkopoulo; S Lipsitz; R G Hahn; D Klaassen
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

9.  Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.

Authors:  P Abraham; S H Ralston; M Hewison; W D Fraser; J S Bevan
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

10.  Cystic pancreatic neuroendocrine neoplasms with uncertain malignant potential: report of two cases.

Authors:  Roberto Ballarin; Michele Masetti; Luisa Losi; Fabrizio Di Benedetto; Stefano Di Sandro; Nicola De Ruvo; Roberto Montalti; Antonio Romano; Gian-Piero Guerrini; Maria-Grazia De Blasiis; Mario Spaggiari; Giorgio Enrico Gerunda
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

View more
  2 in total

Review 1.  Zollinger-Ellison syndrome: recent advances and controversies.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

Review 2.  Pharmacotherapy of Zollinger-Ellison syndrome.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2013-01-30       Impact factor: 3.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.